These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 16842880)

  • 41. Double loading of cyclosporine A in liposomes using cyclodextrin complexes.
    Malaekeh-Nikouei B; Davies N
    PDA J Pharm Sci Technol; 2009; 63(2):139-48. PubMed ID: 19634352
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of liposomal systems containing doxorubicin entrapped in response to pH gradients.
    Mayer LD; Tai LC; Bally MB; Mitilenes GN; Ginsberg RS; Cullis PR
    Biochim Biophys Acta; 1990 Jun; 1025(2):143-51. PubMed ID: 2364073
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enhanced tumor targeting of doxorubicin by ganglioside GM1-bearing long-circulating liposomes.
    Unezaki S; Maruyama K; Ishida O; Takahashi N; Iwatsuru M
    J Drug Target; 1993; 1(4):287-92. PubMed ID: 8069570
    [TBL] [Abstract][Full Text] [Related]  

  • 44. DMPC/Chol liposomal copper CX5461 is therapeutically superior to a DSPC/Chol formulation.
    Leung AWY; Chen KTJ; Ryan GM; Anantha M; Wretham N; Nosrati Z; Heroux D; Wang L; Chow N; Dai Z; Bally MB
    J Control Release; 2022 May; 345():75-90. PubMed ID: 35259461
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro assay for measuring real time topotecan release from liposomes: release kinetics and cellular internalization.
    Gilabert-Oriol R; Chernov L; Anantha M; Dragowska WH; Bally MB
    Drug Deliv Transl Res; 2017 Aug; 7(4):544-557. PubMed ID: 28432657
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of membrane cholesterol on calcium phosphate formation in aqueous suspensions of anionic liposomes.
    Skrtic D; Eanes ED
    Calcif Tissue Int; 1992 Jan; 50(1):55-60. PubMed ID: 1739872
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ionophore-mediated uptake of ciprofloxacin and vincristine into large unilamellar vesicles exhibiting transmembrane ion gradients.
    Fenske DB; Wong KF; Maurer E; Maurer N; Leenhouts JM; Boman N; Amankwa L; Cullis PR
    Biochim Biophys Acta; 1998 Nov; 1414(1-2):188-204. PubMed ID: 9804953
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Encapsulation and retention of chelated-copper inside hydrophobic nanoparticles: Liquid cored nanoparticles show better retention than a solid core formulation.
    Hervella P; Parra E; Needham D
    Eur J Pharm Biopharm; 2016 May; 102():64-76. PubMed ID: 26925504
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Poly(ethylene glycol)-induced and temperature-dependent phase separation in fluid binary phospholipid membranes.
    Lehtonen JY; Kinnunen PK
    Biophys J; 1995 Feb; 68(2):525-35. PubMed ID: 7696506
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development and In Vivo Application of a Water-Soluble Anticancer Copper Ionophore System Using a Temperature-Sensitive Liposome Formulation.
    Gaál A; Garay TM; Horváth I; Máthé D; Szöllősi D; Veres DS; Mbuotidem J; Kovács T; Tóvári J; Bergmann R; Streli C; Szakács G; Mihály J; Varga Z; Szoboszlai N
    Pharmaceutics; 2020 May; 12(5):. PubMed ID: 32443790
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Formulation kit for liposomal doxorubicin composed of lyophilized liposomes.
    Stevens PJ; Lee RJ
    Anticancer Res; 2003; 23(1A):439-42. PubMed ID: 12680245
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The ionophore nigericin transports Pb2+ with high activity and selectivity: a comparison to monensin and ionomycin.
    Hamidinia SA; Tan B; Erdahl WL; Chapman CJ; Taylor RW; Pfeiffer DR
    Biochemistry; 2004 Dec; 43(50):15956-65. PubMed ID: 15595852
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Membrane interactions of ternary phospholipid/cholesterol bilayers and encapsulation efficiencies of a RIP II protein.
    Manojlovic V; Winkler K; Bunjes V; Neub A; Schubert R; Bugarski B; Leneweit G
    Colloids Surf B Biointerfaces; 2008 Jul; 64(2):284-96. PubMed ID: 18359207
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Optimization and characterization of a sphingomyelin/cholesterol liposome formulation of vinorelbine with promising antitumor activity.
    Semple SC; Leone R; Wang J; Leng EC; Klimuk SK; Eisenhardt ML; Yuan ZN; Edwards K; Maurer N; Hope MJ; Cullis PR; Ahkong QF
    J Pharm Sci; 2005 May; 94(5):1024-38. PubMed ID: 15793796
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Topotecan Liposomes: A Visit from a Molecular to a Therapeutic Platform.
    Saraf S; Jain A; Hurkat P; Jain SK
    Crit Rev Ther Drug Carrier Syst; 2016; 33(5):401-432. PubMed ID: 27910741
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ion-Pairing Contribution to the Liposomal Transport of Topotecan as Revealed by Mechanistic Modeling.
    Fugit KD; Anderson BD
    J Pharm Sci; 2017 Apr; 106(4):1149-1161. PubMed ID: 28007561
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In-vitro cytotoxicity, in-vivo biodistribution and anti-tumour effect of PEGylated liposomal topotecan.
    Hao YL; Deng YJ; Chen Y; Wang KZ; Hao AJ; Zhang Y
    J Pharm Pharmacol; 2005 Oct; 57(10):1279-87. PubMed ID: 16259756
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intracellular and serum stability of liposomal 2',3'-dideoxycytidine. Effect of lipid composition.
    Makabi-Panzu B; Gourde P; Désormeaux A; Bergeron MG
    Cell Mol Biol (Noisy-le-grand); 1998 Mar; 44(2):277-84. PubMed ID: 9593578
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A comprehensive mathematical model of drug release kinetics from nano-liposomes, derived from optimization studies of cationic PEGylated liposomal doxorubicin formulations for drug-gene delivery.
    Haghiralsadat F; Amoabediny G; Helder MN; Naderinezhad S; Sheikhha MH; Forouzanfar T; Zandieh-Doulabi B
    Artif Cells Nanomed Biotechnol; 2018 Feb; 46(1):169-177. PubMed ID: 28376641
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Formulation and characterization of boanmycin-loaded liposomes prepared by pH gradient experimental design.
    Liu Y; Yoo SD; Li L; Fang L; Wen Z; Li T
    Drug Deliv; 2012 Feb; 19(2):90-101. PubMed ID: 22283679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.